152 related articles for article (PubMed ID: 21692850)
1. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
Jimenez-Zepeda VH; Neme-Yunes Y; Braggio E
Eur J Haematol; 2011 Jul; 87(1):20-7. PubMed ID: 21692850
[TBL] [Abstract][Full Text] [Related]
2. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
Jimenez-Zepeda VH; Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
[TBL] [Abstract][Full Text] [Related]
3. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
[TBL] [Abstract][Full Text] [Related]
4. Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities.
Jimenez-Zepeda VH; Chng WJ; Schop RF; Braggio E; Leis JF; Kay N; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):467-76. PubMed ID: 23876845
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.
Chng WJ; Ketterling RP; Fonseca R
Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
9. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
[TBL] [Abstract][Full Text] [Related]
11. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Qiu HX; Lu H
Int J Lab Hematol; 2009 Jun; 31(3):338-43. PubMed ID: 18284415
[TBL] [Abstract][Full Text] [Related]
13. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
14. Chromosomes in plasma-cell malignancies.
Van Den Berghe H
Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
[TBL] [Abstract][Full Text] [Related]
15. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
17. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
[TBL] [Abstract][Full Text] [Related]
18. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
[TBL] [Abstract][Full Text] [Related]
20. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
